Samsung Electronics has announced the launch of the trial of the re-open.com solution, a Vital Monitoring System (VMS), on the Samsung Galaxy Watch4 device.
VMS was recently launched in the USA and is part of re-open.com, a cloud-based platform developed in Australia by Deakin University, NTRI, and SaniteX Global.
It aims to support the world as it recovers from COVID-19 and into the future.
Samsung trials VMS on Galaxy Watch4
VMS uses both physical health indicators and self reporting tools to deliver an effective and holistic medical screening tool that is ideal for front-line workers.
The trial will take advantage of the sensors in the Samsung Galaxy Watch4 to enhance the efficiency and convenience of VMS, including the SpO2 sensor and the heart rate monitor.
The Samsung Galaxy Watch4’s SpO2 sensor enables users to monitor their blood oxygen level, thereby offering clear visuals and statistics to assist in tracking and screening.
Deakin University, NTRI and Samsung are investigating the use of the Galaxy Watch4 as a standalone device as it currently requires a compatible Android smartphone.
As Australia and the world recovers from the pandemic, with front-line workers the priority and wider workforces to follow the VMS solution has been designed to give employers and their employees peace-of-mind when it comes to safely returning to the workplace.
The user receives an SMS every morning before work linking to an observation survey where they are asked screening questions and questions about their vital symptoms.
This includes temperature, SpO2, heart rate, COVID-19 signs like body aches, headaches, sore throat and whether they have been in contact with anyone having COVID-19.
Integration with Galaxy Watch4 allows users to fill the questionnaire using their watch which automatically measures SpO2 and Heart Rate and applies it to the questions.
After passing the screening, users receive a QR code granting access to the workplace.
Comments on Samsung’s Galaxy Watch4 VMS trial
Dr Carl Luckhoff, the Acting Director of Emergency at Alfred Health has been involved in developing and trialing the Vital Monitoring System solution.
“Throughout the COVID-19 pandemic, we have been faced with considerable unknowns.”
“That will continue as we move into the next stages of COVID-19 recovery, however, screening measures will play an imperative role in the recovery process,” Dr Carl Luckhoff said.
“VMS is built with that exact purpose in mind and we’re delighted to partner with Samsung to tap into the capabilities of its Galaxy Watch4, which truly complements the VMS solution.”
Danny Mandrides heads Enterprise & Government Mobile Business at Samsung Electronics.
“Partnering with Deakin University and SaniteX Global on the VMS solution provides us with an opportunity to help in the quest to return the world to normality and that is exciting.”
“The Galaxy Watch4’s health monitoring capabilities are a perfect match for the VMS solution to improve user experience by automating the collation of key vitals needed for its survey.”
Professor Kon Mouzakis at Deakin University is enthusiastic about the VMS trial.
“In order for the VMS solution to have the scale and usability that we want it to, we need to meet people where they are, on their favourite platforms, and with a seamless ease-of-use.”
“Samsung’s Galaxy Watch4 is a perfect device for us to partner with in this study.”
“Given the watch’s health tracking capabilities, we are delighted that both current and prospective Galaxy Watch users will be able to utilise their device for VMS screening.”
David A. Collard, SaniteX Global’s Founder and Chief Executive Officer was also enthusiastic.
“The VMS solution has been built through a strong partnership with Deakin University and Alfred Health from the very first conversation we had with Professor Rajesh Vasa.”
“Helping facilitate USA market access and penetration on the re-open.com platform drove the collaborative discussion to broaden the VMS’s application to health screening.”
“Partnering with Samsung and its global capabilities will see VMS scaled to help the individuals who wear the Galaxy Watch4 monitor their wellbeing with ease, making the world safer.”
The strict security measures mean that personal health data is kept secure and confidential.
Data is encrypted to employers. The only people who can ever access the data are clinicians to help in the case of people needing treatment and requiring accessing health records.
The new screening tool is compliant with the highest standard of health privacy regulations.
